Search for content, post, videos

Karolinska Institutet is strengthening its healthcare capacity in virus diagnostics

Through cooperation with a Chinese supplier, financial support from the Knut and Alice Wallenberg Foundation and coordination with the healthcare sector, Karolinska Institutet (KI) aims to strengthen healthcare capacity in virus diagnostics.

Karolinska Institutet’s capabilities are now being coordinated with the healthcare sector’s resources for COVID-19 diagnostics. The coordination is taking place through a collaboration with China and the Science for Life Laboratory (SciLifeLab).

The Wallenberg Foundation is allocating SEK 50 million

Furthermore, the Wallenberg Foundation has announced that it is immediately allocating SEK 50 million to support corona virus testing, both within clinical laboratories and research.

This initiative has been made possible through an international collaboration with the BGI/MGI research institute in Shenzhen in southern China where automatic specimen handling and sequencing instruments for large-scale DNA analysis of the corona virus have been developed.

“This is an important step in increasing capacity and ensuring quick and safe testing. In addition to our own staff, numerous individuals with relevant laboratory experience have volunteered to make this happen,” says Lars Engstrand, Professor of Infectious Diseases and director of KI’s and SciLifeLab’s Center for Translational Microbiome Research (CTMR). “All support and all initiatives are important right now, both those that address more immediate issues and those that both now and in the future increase our understanding of the new corona virus. We have now secured the capacity to carry out a large number of analyses.”

 

Lars Engstrand

Photo of Lars Engstrand: Andreas Andersson